These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2948194)
1. T cells and their products in host responsiveness to organ allografts. Tilney NL; Kupiec-Weglinski J; Strom TB Prog Clin Biol Res; 1986; 224():21-39. PubMed ID: 2948194 [No Abstract] [Full Text] [Related]
2. An immunohistochemical study of lymphocytes occurring in heart allografts in rats. Kogure K; Kudo S Transplant Proc; 1992 Oct; 24(5):1656. PubMed ID: 1412785 [No Abstract] [Full Text] [Related]
3. Prevention of rejection by treatment of the graft: an overview. Lafferty KJ; Babcock SK; Gill RG Prog Clin Biol Res; 1986; 224():87-117. PubMed ID: 2948196 [TBL] [Abstract][Full Text] [Related]
8. W3/25+ and OX8+ T suppressor cells are required to maintain transplantation tolerance. Duncan WR; Bitter-Suermann H; Stepkowski SM Transplant Proc; 1987 Feb; 19(1 Pt 1):551-2. PubMed ID: 2978924 [No Abstract] [Full Text] [Related]
9. The possible role of cytotoxic T cells in the mediation of first-set allograft rejection. Hall BM; Gurley KE; Dorsch SE Transplantation; 1985 Sep; 40(3):336-9. PubMed ID: 2930923 [No Abstract] [Full Text] [Related]
10. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. Williams IR; Perry LL J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920 [TBL] [Abstract][Full Text] [Related]
11. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies. Bhan AK; Mihm MC; Dvorak HF J Immunol; 1982 Oct; 129(4):1578-83. PubMed ID: 6213716 [TBL] [Abstract][Full Text] [Related]
12. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS; Sharrow SO; Shearer GM J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440 [TBL] [Abstract][Full Text] [Related]
13. Insulin-determinant recognition by helper and suppressor T cells. Kapp JA; Whiteley PJ Chem Immunol; 1989; 46():85-100. PubMed ID: 2575391 [No Abstract] [Full Text] [Related]
14. Immunoregulatory T lymphocytes in man. Cell surface molecules involved in their function. Damle NK; Engleman EG Year Immunol; 1985; ():39-50. PubMed ID: 2953144 [No Abstract] [Full Text] [Related]
15. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin. Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286 [TBL] [Abstract][Full Text] [Related]
16. Cytokine products of T-helper 2 (Th2) cells are present in rejecting sponge matrix allografts. Wang SC; Tweardy DJ; Ford HR; Hoffman RA; Simmons RL Transplant Proc; 1991 Feb; 23(1 Pt 1):809-10. PubMed ID: 1824998 [No Abstract] [Full Text] [Related]
17. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts. Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926 [No Abstract] [Full Text] [Related]
18. Frequencies of donor-reactive helper T lymphocytes correlate with rejection of aortic valve allografts in rats. Dor FJ; Oei FB; Vaessen LM; Marquet RL; Bogers AJ; Weimar W J Heart Valve Dis; 2002 May; 11(3):326-34. PubMed ID: 12056722 [TBL] [Abstract][Full Text] [Related]